Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$605,712
+$133,870 QoQ
Shares Held
505
-1.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#3,592
of 4,605 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LAWOOD & CO holds $11,999,701 across 7 Drug Manufacturers - General names. LLY ranks #5 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,185 | $3,856,533 | |
| 2 | ABBV |
AbbVie Inc.
|
12,003 | $3,020,434 | |
| 3 | MRK |
Merck & Co., Inc.
|
23,298 | $2,993,793 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
5,784 | $730,749 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
505 | $605,712 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,561 | $435,664 | |
| 7 | PFE |
Pfizer Inc
|
14,818 | $356,816 |
All Filings in LLY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $605,712 | 505 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $471,842 | 513 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $551,310 | 513 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||